Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

B-MS' nivolumab impresses in Phase II lung cancer trial

B-MS' nivolumab impresses in Phase II lung cancer trial

NICE backs expanded use of BI's Pradaxa

NICE backs expanded use of BI's Pradaxa

Bristol checkmates lung study and trades like a biotech

Until this week pharma companies tended to represent relatively stable investments not prone to the share price swings of their smaller, biotech counterparts. But then Sanofi’s chief...

Approval of Abiomed’s Impella impending after FDA waives panel

Shares in the heart pump maker Abiomed closed up 24% yesterday on the news that it will not have to run the gauntlet of an FDA adcom for its flagship Impella heart failure device – a...
more news